Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


NeoTract brings in $26mm through undisclosed late-stage equity round

Executive Summary

NeoTract Inc. (urological devices) brought in $26mm through an undisclosed equity round in which five investors participated. The company most recently raised a Series B round totaling $28.1mm and to date has raised $74mm. Its UroLift permanent implant to treat benign prostatic hyperplasia received the CE mark last year.
Deal Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies